Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
ClinicalTrials.gov identifiers NCT02675426, NCT02706951, NCT02706847, NCT02629159, NCT02706873, NCT03086343, NCT03104374, NCT03104400, NCT03178487, NCT04169373, NCT03569293, NCT03568318, NCT03607422, NCT03345823, NCT02819635.
Authors
- Sharanya Ford
- Kevin L. Winthrop (ORCID: https://orcid.org/0000-0002-3892-6947)
- Gweneth Levy
- Remo Panaccione (ORCID: https://orcid.org/0000-0002-5247-940X)
- Emma Guttman‐Yassky (ORCID: https://orcid.org/0000-0002-9363-324X)
- Ruth Ann Vleugels (ORCID: https://orcid.org/0000-0001-8446-7115)
- Sebastian Meerwein
- Lani R. Wegrzyn
- Atul Deodhar (ORCID: https://orcid.org/0000-0002-2130-1246)
- Hannah Palac (ORCID: https://orcid.org/0000-0003-1314-3329)
- Gerd R Burmester (ORCID: https://orcid.org/0000-0001-7518-1131)
- Alan D. Irvine (ORCID: https://orcid.org/0000-0002-9048-2044)
- Smitha Suravaram
Institutions
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Harvard University (US)
- Oregon Health & Science University (US)
- University of Calgary (CA)
- Trinity College Dublin (IE)
- AbbVie (United States) (US)
- Humboldt-Universität zu Berlin (DE)
- AbbVie (Germany) (DE)
- Boston Children's Museum (US)
- St. James's Hospital (IE)
- Charité - Universitätsmedizin Berlin (DE)
- Rockefeller University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1007/s12325-025-03328-y
- Citations
- 6
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 4.78
Funders
- AbbVie
- Charité – Universitätsmedizin Berlin